01446nam a2200229   4500001000700000010001500007090001100022100004100033101000800074200016700082210008300249215001800332225003100350330051700381606004900898606002400947606003000971606001701001710006801018955001101086995011901097384311  a9291681377  a384311  a20070529d2003       y0pory50      ba  aeng  aReport on the risk assessment of PMMA in the framework of the joint action on new synthetic drugsfEuropean Monitoring Centre for Drugs and Drug Addiction, EMCDDA  aLuxembourgcOffice for Official Publications of the European Communitiesd2003  a122 p.d21 cm  aEMCDDA Risk Assessmentsv5  aForeword. Abbreviations. Introduction. Chapter 1: Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs. Chapter 2: Council decision. Chapter 3: Europol-EMCDDA progress report on PMMA and PMA. Chapter 4: Review of the pharmacotoxicological data on PMMA. Chapter 5: Sociological and criminological evidence on the risks of PMMA. Chapter 6: Public health risks of PMMA - epidemiological evidence. References. Participants in the risk assessment process. Further reading.  aPREVENÇÃO DA TOXICODEPENDÊNCIA9103892  aRELATÓRIO9410454  aDROGA SINTÉTICA9320915  aOEDT9321506  aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION9351987  xOferta  104PJ_19_000000000000000_D_8152022-06-066PJ280829414200aPJcPJfPJ128082kPJ19.D.81n2022-06-06o0rMOxOferta